| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.44B | +1.0% |
| Cost of Revenue | $2.07B | +1.1% |
| Gross Profit | $1.37B | +1.0% |
| R&D Expense | $71.9M | +8.1% |
| SG&A Expense | $876.1M | +0.7% |
| Operating Income | $465.3M | -2.8% |
| Pre-tax Income | $340.2M | +3.7% |
| Income Tax | $63.1M | -41.3% |
| Net Income | $251.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $812.1M | +19.1% |
| Accounts Receivable | $744.2M | +3.0% |
| Inventory | $700.0M | +3.6% |
| Current Assets | $2.48B | +7.6% |
| Total Assets | $7.15B | +5.4% |
| Current Liabilities | $735.4M | +1.9% |
| Long-term Debt | $2.23B | -5.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $478.1M | +25.9% |
| Capital Expenditures | $73.2M | -11.9% |
| Investing Cash Flow | -$119.0M | -14.0% |
| Financing Cash Flow | -$251.1M | +12.4% |
| Free Cash Flow | $404.9M | +36.6% |
| +29.0% |
| EPS (Basic) | $0.98 | +30.7% |
| EPS (Diluted) | $0.96 | +29.7% |
| Total Liabilities |
| $3.46B |
| +0.5% |
| Stockholders' Equity | $3.33B | +10.3% |